SA
REGN icon

Sanctuary Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Sanctuary Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9M Sell
39,923
-708
-2% -$482K 0.12% 186
2026
Q1 		$31.4M Buy
40,631
+1,649
+4% +$1.26M 0.17% 124
2025
Q4 		$30.1M Buy
38,982
+45
+0.1% +$30.6K 0.16% 124
2025
Q3 		$21.9M Buy
38,937
+5,095
+15% +$2.88M 0.13% 180
2025
Q2 		$17.8M Sell
33,842
-282
-0.8% -$157K 0.11% 200
2025
Q1 		$21.6M Sell
34,124
-1,647
-5% -$1.13M 0.15% 150
2024
Q4 		$24.4M Sell
35,771
-167
-0.5% -$140K 0.15% 137
2024
Q3 		$26.5M Sell
35,938
-9,361
-21% -$10.4M 0.17% 127
2024
Q2 		$40M Buy
+45,299
New +$43.9M 0.29% 60

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sanctuary Advisors's REGN Position: Q2 2026 in Review

Sanctuary Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 1.7% in Q2 2026, selling an estimated $482K and leaving 39,923 shares worth $24.9M. The position accounts for 0.12% of the portfolio, ranked #186.

Sanctuary Advisors first reported a position in REGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $40M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Sanctuary Advisors held 39,923 shares of Regeneron Pharmaceuticals worth $24.9M as of Q2 2026.
  • Sanctuary Advisors sold 708 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $482K.
  • Regeneron Pharmaceuticals made up 0.12% of Sanctuary Advisors's portfolio in Q2 2026, its #186 holding.
  • Sanctuary Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Regeneron Pharmaceuticals position peaked at $40M in Q2 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.